An early MRD reduction ≥ 3 log has been shown to significantly lower the incidence of relapse in multivariate analysis[24], whereas MRD persistence in blood at the end of treatment is associated with higher levels of relapse in CBF-AML with t(8;21)[25]. Here, CEBPZ is linked to acute myeloid leukemia.